203 filings
Page 3 of 11
8-K
xx6zkprr wvz5m
3 Jul 14
Raptor Pharmaceutical Enters into $70 Million Financing Transaction and Amended Loan Agreement with HealthCare Royalty Partners
12:00am
8-K
2bpltq
8 May 14
Raptor Pharmaceutical Reports First Quarter 2014 Financial Results and Provides Corporate Update
12:00am
8-K
2u4b9f4ctfoqewzhl9
13 Mar 14
Raptor Pharmaceutical Reports Fourth Quarter and Full Year 2013 Financial Results and Provides Corporate Update
12:00am
8-K
9khj28ioc486rttpa0do
26 Feb 14
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
qsw2 3w1cs
24 Feb 14
18 Month Clinical Results Showed Significantly Slower Progression of Total Motor Score in RP103 Treated Patients Without Tetrabenazine
12:00am
8-K
rafzc
22 Jan 14
Changes in Registrant's Certifying Accountant
12:00am
8-K
ztmy8rzyq7egnmrn
14 Jan 14
Raptor Announces Full Enrollment of Phase 2b Trial of RP103 for Non-Alcoholic Fatty Liver Disease in Children
12:00am
8-K
c8znu3xv7b7g7 ze
12 Dec 13
Raptor Submits IND for RP103 for Leigh Syndrome and Other Mitochondrial Disorders
12:00am
8-K
dos58xlslpxz
7 Nov 13
Third Quarter 2013 Financial Results
12:00am
8-K
588o8775gfqh8
12 Sep 13
Other Events
12:00am
8-K
754sfxy 2ftru
8 Aug 13
Second Quarter 2013 Financial Results
12:00am
8-K
mkm8a7j77ag
25 Jul 13
Departure of Directors or Certain Officers
12:00am
8-K
eg9m2fjy58j9
23 Jul 13
PROCYSBI® Receives Positive Opinion for Orphan Drug Exclusivity From the EU Committee for Orphan Medicinal Products
12:00am
8-K
uyj1up sop8cxgz
5 Jul 13
Entry into a Material Definitive Agreement
12:00am
8-K
0fzcl l6ky
2 Jul 13
Raptor Pharmaceutical's PROCYSBI™ Receives Positive Recommendation From CHMP
12:00am
8-K
um1rv
25 Jun 13
Raptor's PROCYSBI™ Receives U.S. Orphan Drug Exclusivity
12:00am
8-K
ol7mtc
24 May 13
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
12:00am
8-K
574yvqn0zncvroln
9 May 13
Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results
12:00am
8-K
ppmzmjz3ux
1 May 13
Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of
12:00am
8-K
6xkax6y2cz7olaww 47
9 Apr 13
Entry into a Material Definitive Agreement
12:00am